RBC Capital analyst Sabahat Khan raised the firm’s price target on Legence (LGN) to $48 from $36 and keeps an Outperform rating on the shares. Legence reported a strong inaugural quarter as a public company, with revenue and adjusted EBITDA above consensus, supported by the various megatrends that Legence is exposed to, while 4Q25 and 2026 guidance were also ahead at the midpoint, the analyst tells investors in a research note.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
- Legence price target raised to $46 from $37 at Goldman Sachs
- Legence price target raised to $37 from $34 at Barclays
- Legence price target raised to $45 from $40 at BTIG
- Legence Corp. Receives Buy Rating Amid Strong Financial Performance and Strategic Growth Initiatives
- Legence Corp. Reports Strong Q3 2025 Results and Strategic Acquisitions